clenoliximab (IDEC-151) / Biogen - LARVOL DELTA

Bioinformatic analysis combined with immune infiltration to explore osteoarthritis biomarkers and drug prediction. (PubMed, Medicine (Baltimore)) - "The validation of immune infiltration results indicated that NK_cells, CD4_Tcells, Macrophages, Monocytic_lineage, Dendritic_cells, Basophils, CD8+_naive_T-cells may play an important role in the immune process of OA. Key Drug Prediction of Hub Genes found that Halicin, Ruxolitinib, Tofacitinib, Clenoliximab, Baricitinib may be a key drug or component in the treatment of OA."

Biomarker • Journal • Immunology • Inflammation • Osteoarthritis • Pain • Rheumatology • CD4 • CD8 • EGFR • JAK2 • MAPK8 • SCARB1 • SERPINE1 • TGFB1 • TP53